The effect of exposure to a commercial 2,4-D herbicide formulation during gestation on urethan-induced lung adenoma formation in CD-1 mice

Veterinary and Human Toxicology

Volumn 42, Issue 3, 2000, Pages 129-132

  Lee, Kwangjick ^a   Johnson, Victor J ^a   Blakley, Barry R ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DICHLOROPHENOXYACETIC ACID; HERBICIDE; URETHAN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL GROWTH; CONTROLLED STUDY; FEMALE; IMMUNOSURVEILLANCE; LUNG ADENOMA; MOUSE; NONHUMAN; PRENATAL EXPOSURE; SLEEP TIME; TUMOR VOLUME;

2,4-DICHLOROPHENOXYACETIC ACID; ADENOMA; ANIMALS; CARCINOGENS; FEMALE; HERBICIDES; INJECTIONS, INTRAPERITONEAL; LUNG NEOPLASMS; MALE; MATERNAL EXPOSURE; MICE; NEOPLASMS, EXPERIMENTAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SLEEP; URETHANE; WEIGHT GAIN;

EID: 0034029861     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gorzinski SJ, Kociba RJ, Campbell RA et al: Acute, pharmacokinetic, and subchronic toxicological studies of 2,4-D. Fundamental Applied Toxicology 9: 423-435, 1987.
2. nd Ed. Kendall/Hunt Publishing, Dubuque, IA, 1976.
3. Seabury JH: Toxicity of 2,4-dichlorophenoxyacetic acid for man and dog. Archives of Environmental Health 7: 202-207, 1963.
4. WHO: The WHO Recommended Classification of Pesticide by Hazard and Guidelines to Classification 1996-1997, International Programme on Chemical Safety, Geneva, 1996.
5. WHO: Pesticide Residues in Food, Toxicological Evaluations for 2,4-D. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Expert Group on Pesticides Residues, Rome, 1997.
6. Ibrahim MA, Bond GG, Burke TA et al: Weight of the evidence on the human carcinogenicity of 2,4-D. Environmental Health Perspectives 96:213-222, 1991.
7. Kinlen LJ: Immunosuppression and cancer. In Vanio H, Magee PN, McGregor DB et al eds: Mechanism of Carcinogenesis in Risk Identification. Lyon: International Agency for Research on Cancer 237-253, 1992.
8. Linnainmaa K: Induction of sister chromatid exchanges by the peroxisome proliferators, 2,4-D, MCPA, and clofibrate in vivo and in vitro. Carcinogenesis 5: 703-707, 1984.
9. Blakley BR, Blakley PM: The effect of prenatal exposure to the n-butylester of 2,4-D on the immune response in mice. Teratology 33:15-20, 1986.
10. Blakley BR, Schiefer HB: The effect of topically applied n-butylester of 2,4-D on the immune response in mice. Journal Applied Toxicology 6: 291-295, 1986.
11. Blakley BR: The effect of oral exposure to the n-butylester of 2,4-D on the immune response in mice. International Journal Immunopharmacology 8:93-99, 1986.
12. Faustini A, Settimi L, Pacifici R et al: Immunological changes among farmers exposed to phenoxy herbicides: preliminary observations. Occupational and Environmental Medicine 53: 583-585, 1996.
13. Reuber MD: Carcinogenicity and toxicity of 2,4-D Science Total Environment 31:203-218, 1983.
14. Hazleton Laboratories America Inc: Oncogenicity study in mice with 2,4-D, Final report, Vol. 1. Prepared for the Industry Task Force on 2,4-D Research Data. Hazleton Vienna, VA, 1986.
15. Adams SL, Horvat ST, Irwin AE et al. The effect of Tordon 202C exposure on urethan-induced lung adenoma formation in female CD-1 mice. Veterinary Human Toxicology 33: 209-211, 1991.
16. Blakley BR, Gagnon JM: The effect of a commercial 2,4-D formulation on chemical and viral induced tumor production in mice. Journal Applied Toxicology 12: 245-249, 1992.
17. Holladay SD, Luster MI: Developmental immunotoxicology. In Kimmel CA, Buelke-Sam J Eds: Developmental Toxicology, 2nd Ed. Raven Press: 93-118, 1994.
18. Shimkin MB, Stoner GD: Lung tumors in mice: application to carcinogenesis bioassay. Advances Cancer Research 21: 1-58, 1975.
19. O'Flaherty EJ, Sichak SP: The kinetics of urethan elimination in the mouse Toxicology Applied Pharmacology 68: 354-358, 1983.
20. Menard S, Colnaghi M, Cornalba G: Immunogenicity and immunosensitivity of urethan-induced murine lung adenoma in relation to the immunological impairment of the primary tumor host. Britain Journal Cancer 27: 345-350, 1973.
21. Trainin N, Linker-Israeli M: Influence of immunosuppression and immunorestoration on the formation of urethan-induced adenomas. Journal National Cancer Institute 44:893-900, 1970.
22. Lappe MA, Prehn RT: The predictive value of skin allograft survival times during the development of urethan-induced lung adenomas in BALB/c mice. Cancer Research 30:1357-1361, 1970.
23. Colnaghi MI, Menard S, Porta GD: Demonstration of cellular immunity against urethan-induced lung adenomas in mice. Journal National Cancer Institute 47:1325-1331, 1971.
24. Miyashita N, Moriwaki K, Migita S: The H-2 class ? genes and the susceptibility to the development of pulmonary adenoma in mice. Immunogenetics 29: 14-18, 1989.
25. Roitt I, Brostoff J, Male D: Immunology, 4th Ed. Mosby: Chapter 20, 1996.
26. Sastry BVR, Janson VE, Clark CP et al: Cellular toxicity of 2,4,5-trichlorophenoxyacetic acid: Formation of 2,4,5-trichlorophenoxyacetylcholine. Cellular Molecular Biology 43: 549-557, 1997.
27. Rivarola V, Balegno H: 2,4-D effects on polyamine biosynthesis. Toxicology 68: 109-119, 1991.
28. Tabor CW, Tabor H: Polyamines. Annual Review of Biochemistry 53: 749-790, 1984.